Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANIX

Anixa Biosciences Inc

May 27 • 04:00PM ET

2.65

-0.08 -2.93 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ATYR COYA CYPH INO LONA NRXS CGTX KLRS NRXP KALA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.32	Insider Own	5.38%	Shs Outstand	33.46M	Perf Week	-0.75%
Market Cap	88.85M	Forward P/E	-	EPS next Y	-0.35	Insider Trans	0.56%	Shs Float	31.72M	Perf Month	-10.77%
Enterprise Value	73.61M	PEG	-	EPS next Q	-0.09	Inst Own	15.23%	Short Float	3.10%	Perf Quarter	-12.25%
Income	-10.31M	P/S	-	EPS this Y	1.47%	Inst Trans	-2.10%	Short Ratio	9.06	Perf Half Y	-38.94%
Sales	0.00M	P/B	5.88	EPS next Y	-4.48%	ROA	-60.39%	Short Interest	0.98M	Perf YTD	-15.06%
Book/sh	0.45	P/C	6.26	EPS next 5Y	-3.32%	ROE	-62.61%	52W High	5.46 -51.43%	Perf Year	6.00%
Cash/sh	0.42	P/FCF	-	EPS past 3/5Y	9.05% 5.67%	ROIC	-67.69%	52W Low	2.44 8.61%	Perf 3Y	-17.70%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.04% 5.04%	Perf 5Y	-33.42%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	19.02%	Oper. Margin	-	ATR (14)	0.14	Perf 10Y	-16.40%
Dividend Ex-Date	-	Quick Ratio	12.18	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	38.73	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	12.18	EPS Q/Q	21.94%	SMA20	-8.26%	Beta	0.61	Target Price	11.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-6.17%	Rel Volume	0.63	Prev Close	2.73
Employees	4	LT Debt/Eq	0.01	Earnings	Mar 13	SMA200	-20.58%	Avg Volume	108.54K	Price	2.65
IPO	Oct 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.21% -	Trades		Volume	68,658	Change	-2.93%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)